1. Home
  2. News
  3. Henan Lingrui Pharmaceutial Co., Ltd.
  4. (600285)"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Report for Q3 2026
More Henan Lingrui Pharmaceutial Co., Ltd. news
Henan Lingrui Pharmaceutial Co., Ltd.SSE: 600285

(600285)"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Report for Q3 2026

Oct 30, 2026 · Issued by Henan Lingrui Pharmaceutial Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 600285 · Oct 30, 2026 · 12 pages · Chinese

On 6ix: 6ix.com/news/600285henan-lingrui-pharmaceutical-co-ltdreport-for-q3-2026

Henan Lingrui Pharmaceutial Co., Ltd. on 6ix

Earlier from Henan Lingrui Pharmaceutial

  • (600285)"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Announcement on Release of Pledge of Certain Shares Held by Major ShareholderOct 14
  • (600285)"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Announcement on Release of Pledge and Re-pledge of Certain Shares Held by Major ShareholderSep 30
  • Announcement on Pledge of Certain Shares Held by Major ShareholderAug 22
  • Semi-annual Report for 2026Aug 12
  • Announcement on Inclusion of Products of the Company and Its Subsidiaries in the "National Essential Medicines List (2026 Edition)"Jul 11
All Henan Lingrui Pharmaceutial news releases↗

Follow Henan Lingrui Pharmaceutial into a list and get an email when it puts out news.

Follow Henan Lingrui Pharmaceutial
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer